ClearKone® Prescribed to More than 16,000 Patients in 32 Countries

     

    CARLSBAD, Calif., July 22, 2011 — SynergEyes, Inc., the leader in hybrid contact lens technology, announced that ClearKone®, its second generation hybrid contact lens for irregular corneas, has been prescribed to more than 16,000 patients in 32 countries since the lens became available in la…

    (Read More...) 301 views

    SynergEyes and Insight Your Vision Source Grant a Life-Changing Gift This Summer: Seeing the World Clearly for the First Time in Three Years

     

    ATLANTA, July 13, 2011 — This summer, Denise Filmore has received the life-changing gift of clear and comfortable vision thanks to the Sharing Vision Grant Program™ sponsored by SynergEyes, Inc. and Dr. David Sweeney at Insight Your Vision Source. This program was created to bring the new, tec…

    (Read More...) 379 views

    SynergEyes Grants Life-Changing Gift for Holidays: Ability to Distinguish Family Faces

     

    Keratoconus Patients Granted New Hybrid Contact Lens Technology
    CARLSBAD, Calif., Dec. 21, 2010 — This holiday season patients are receiving the life-changing gift of clear and comfortable vision thanks to the Sharing Vision Grant Program sponsored by SynergEyes, Inc. This program was creat…

    (Read More...) 440 views

    SynergEyes(R) Launches TreatKeratoconus.com: A New Website for Keratoconus Patients

     

    CARLSBAD, Calif., Sept. 24, 2010 — SynergEyes, Inc., the developer of ClearKone(R), the FDA-cleared hybrid contact lens specifically designed to treat keratoconus, has launched a new educational website, http://www.treatkeratoconus.com, for patients seeking information and treatment…

    (Read More...) 353 views

    ClearKone(TM) by SynergEyes(R) Awarded Most Innovative New Product of 2009

     

    CARLSBAD, Calif., Dec. 21, 2009 — CONNECT(R), one of the nation’s most successful organizations dedicated to creating and sustaining the growth of innovative technology and life science businesses, announced SynergEyes, Inc., the high Dk hybrid contact lens manufacturer, as the winn…

    (Read More...) 592 views

    CONNECT(R) Announces ClearKone(TM) by SynergEyes(R) As Finalist for Most Innovative New Product Award

     

    CARLSBAD, Calif., Oct. 21, 2009 — CONNECT(R), a non-profit organization dedicated to creating and sustaining the growth of innovative technology and life science businesses in San Diego, announced SynergEyes, Inc., the high Dk hybrid contact lens manufacturer, as a finalist for its 22nd annu…

    (Read More...) 715 views

    SynergEyes, Inc. Expands Launch of New Hybrid Contact Lens Design for Keratoconus Patients

     

    CARLSBAD, Calif., Sept. 4, 2009 — SynergEyes, Inc., the high Dk hybrid contact lens manufacturer, recently introduced a new advanced lens design for keratoconus patients. ClearKone(TM) is a revolutionary contact lens that takes advantage of the best features of the hybrid platform, providin…

    (Read More...) 778 views

    SynergEyes, Inc. Launches New Hybrid Lens Design for Keratoconus Patients

     

    CARLSBAD, Calif., July 20, 2009 — SynergEyes, Inc., the high Dk hybrid contact lens manufacturer, recently introduced a new advanced lens design for keratoconus patients. ClearKone(TM) is a revolutionary contact lens that takes advantage of the best features of the hybrid platform, providin…

    (Read More...) 1,334 views

    SynergEyes(R) Launches a New Website for Keratoconus Patients

     

    CARLSBAD, Calif., March 11, 2009 — SynergEyes, Inc., the developer of the first FDA-cleared hybrid contact lens specifically designed for patients with keratoconus, has launched a new educational website (http://www.SharingOneVision.com) for patients seeking information on the eye dise…

    (Read More...) 768 views

    SynergEyes, Inc. Raises $13.3 Million in ‘Series C’ Financing

     

    CARLSBAD, Calif., Feb. 6, 2009 — SynergEyes, Inc., the high Dk hybrid contact lens manufacturer, announced today the closing of $13.3 million in Series C financing to fund the development and clinical trials for next-generation hybrid contact lens products and to expand sales and marketing eff…

    (Read More...) 756 views